Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

Young adults who had liver disease as children often experience significant health problems and frequently need transplants.

Finasteride and dutasteride may cause depression and anxiety, especially in younger men.

Xiaozhi Yufa decoction may help treat hair loss by improving hair growth and reducing inflammation.

Metformin helps manage PCOS by improving metabolism and ovulation, but should be part of a personalized treatment plan.

Finasteride harms Daphnia magna's reproduction, growth, and metabolism.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Vegetarians should take B vitamin supplements to avoid health issues.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Skin problems are very common in people with end-stage kidney disease.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

Dysregulated lipid metabolism may play a role in male pattern baldness.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Testosterone boosts red blood cell production and changes iron metabolism without needing dihydrotestosterone.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Both Diane 35 combinations effectively and safely reduce hirsutism and acne, with potential for better results if treatment extends beyond 12 months.

Polynucleotide-based treatments effectively reduce aging signs and aid tissue recovery.

Whalgichan improved hair growth, reduced hair loss, and enhanced cholesterol and lipid metabolism without side effects.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Hydroxychloroquine helped improve scleromyxoedema in patients, but caused side effects in some.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.